Analysis of 14 CAG repeat-containing genes in schizophrenia

Area of Science:

• Neurogenetics
• Psychiatric Genetics

Background:

• Trinucleotide repeat-containing genes are implicated in the etiology of schizophrenia.
• Investigating CAG repeat allelic variants and expansions is crucial for understanding schizophrenia's genetic underpinnings.
• Variability in neuroleptic responsiveness among schizophrenic patients necessitates exploring genetic factors.

Purpose of the Study:

• To investigate associations between CAG repeat-containing genes (CAGrCG) and schizophrenia.
• To examine the relationship between CAG repeat allelic variants and neuroleptic responsiveness in schizophrenic patients.
• To compare CAG repeat allelic variants in neuroleptic-responder, neuroleptic-nonresponder, and control groups.

Main Methods:

• Compared CAG repeat allelic variants of 14 expressed sequences across three subject groups: neuroleptic responders (R), non-responders (NR), and controls (C).
• Analyzed CAG repeat sizes for the hGT1 gene using Kruskal-Wallis and Mann-Whitney tests.
• Assessed for CAG expansions within the range observed in neurodegenerative diseases.

Main Results:

• No significant CAG expansions were identified in the 14 expressed sequences.
• The hGT1 gene exhibited marginally different CAG repeat sizes among the three groups (P = 0.047).
• Neuroleptic responders (R) presented with significantly shorter hGT1 alleles compared to controls (P = 0.0012); NR patients did not differ from controls.

Conclusions:

• The hGT1 gene, or a nearby gene, may be involved in the etiology of schizophrenia.
• The hGT1 gene might play a role in modifying schizophrenia phenotype, influencing disease outcome or neuroleptic responsiveness.
• These preliminary findings warrant further investigation into the role of hGT1 in schizophrenia.